sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 13/09/2007
PIL Tavanic i.v.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/09/2007 and displayed until Current
Reasons for adding or updating:
  • Change of manufacturer
Updated on 22/09/2006 and displayed until 13/09/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/03/2005 and displayed until 22/09/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 17/09/2003 and displayed until 16/03/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 12/12/2000 and displayed until 17/09/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 07/02/2000 and displayed until 12/12/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   levofloxacin